Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bortezomib Regimen”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)UnknownNCT04065308
What this trial is testing

Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma

Who this might be right for
Multiple Myeloma in RelapsePlasmacytomaDaratumumab
Seoul National University Hospital 33
Testing effectiveness (Phase 2)UnknownNCT00378755
What this trial is testing

Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 62
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT03850366
What this trial is testing

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

Who this might be right for
Hematological Malignancy
Henry Ford Health System 15
Not applicableStudy completedNCT07206810
What this trial is testing

The Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Myeloma
The First Affiliated Hospital of Soochow University 419
Early research (Phase 1)UnknownNCT05982756
What this trial is testing

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

Who this might be right for
BortezomibAcute Myeloid Leukemia
Zhongnan Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00992446
What this trial is testing

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Diffuse Large B-Cell LymphomaB-Cell Non-Hodgkin LymphomaFollicular Lymphoma+3 more
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00784823
What this trial is testing

Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 32
Large-scale testing (Phase 3)Looking for participantsNCT03643276
What this trial is testing

Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
Martin Schrappe 5,000
Not applicableUnknownNCT02976272
What this trial is testing

Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple

Who this might be right for
Multiple MyelomaBortezomib RegimenAdult
University Hospital, Clermont-Ferrand 60
Testing effectiveness (Phase 2)Looking for participantsNCT06034561
What this trial is testing

Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission
Instituto do Cancer do Estado de São Paulo 50
Not applicableActive Not RecruitingNCT05013190
What this trial is testing

NINLARO® in Chinese Adults With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Takeda 72
Testing effectiveness (Phase 2)Study completedNCT01702831
What this trial is testing

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 78
Testing effectiveness (Phase 2)Study completedNCT00531453
What this trial is testing

Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 98
Testing effectiveness (Phase 2)Study completedNCT00307086
What this trial is testing

Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
H. Lee Moffitt Cancer Center and Research Institute 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04653246
What this trial is testing

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM

Who this might be right for
Multiple MyelomaNewly Diagnosed Multiple Myeloma (NDMM)Autologous Stem Cell Transplant
Jacob Laubach, MD 52
Testing effectiveness (Phase 2)Study completedNCT00210327
What this trial is testing

VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

Who this might be right for
Lymphoma, Mucosa-Associated Lymphoid Tissue
International Extranodal Lymphoma Study Group (IELSG) 33
Testing effectiveness (Phase 2)Study completedNCT01457144
What this trial is testing

Study of Mantle Cell Lymphoma Treatment by RiBVD

Who this might be right for
Mantle Cell Lymphoma
French Innovative Leukemia Organisation 76
Large-scale testing (Phase 3)Ended earlyNCT00522392
What this trial is testing

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Ended earlyNCT01729338
What this trial is testing

Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 17
Load More Results